AT289824B - Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen - Google Patents

Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen

Info

Publication number
AT289824B
AT289824B AT605769A AT605769A AT289824B AT 289824 B AT289824 B AT 289824B AT 605769 A AT605769 A AT 605769A AT 605769 A AT605769 A AT 605769A AT 289824 B AT289824 B AT 289824B
Authority
AT
Austria
Prior art keywords
amides
esters
salts
production
xanthene derivatives
Prior art date
Application number
AT605769A
Other languages
English (en)
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL6711975A external-priority patent/NL150793B/xx
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Application granted granted Critical
Publication of AT289824B publication Critical patent/AT289824B/de
Priority claimed from US00352504A external-priority patent/US3855406A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/88Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • C07D335/14Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • C07F7/0892Compounds with a Si-O-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT605769A 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen AT289824B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB05692/67A GB1181673A (en) 1966-09-02 1966-09-02 Derivatives of Xanthen and Thiaxanthen and Preparation Thereof
GB3938466 1966-09-02
NL6711975A NL150793B (nl) 1966-09-02 1967-08-31 Werkwijze voor het bereiden van een geneesmiddel met een werking tegen zweren en onder toetoepassing van deze werkwijze verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van hiervoor geschikte geneeskrachtige xantheen- of thioxantheenderivaten.
US00352504A US3855406A (en) 1966-09-02 1973-04-19 Thiaxanthene derivatives useful for treating peptic ulcers

Publications (1)

Publication Number Publication Date
AT289824B true AT289824B (de) 1971-05-10

Family

ID=27448321

Family Applications (2)

Application Number Title Priority Date Filing Date
AT806467A AT296324B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten
AT605769A AT289824B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT806467A AT296324B (de) 1966-09-02 1967-09-01 Verfahren zur Herstellung von neuen Xanthenderivaten

Country Status (9)

Country Link
US (6) US3644420A (de)
AT (2) AT296324B (de)
CA (1) CA962686A (de)
CH (1) CH491104A (de)
CS (2) CS186702B2 (de)
DE (1) DE1643244A1 (de)
ES (1) ES344599A1 (de)
FR (1) FR8016M (de)
GB (1) GB1181673A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886169A (en) * 1966-09-02 1975-05-27 Boots Co Ltd Xanthenyl and thiaxanthenyl semicarbazides
US3735327A (en) * 1972-01-07 1973-05-22 Cts Corp Variable resistance control
US3961069A (en) * 1975-04-23 1976-06-01 Smithkline Corporation Akenyl(or alkynyl) 9-xanthenyl ether compounds
US4005208A (en) * 1975-05-16 1977-01-25 Smithkline Corporation N-Heterocyclic-9-xanthenylamines
US3949076A (en) * 1975-05-29 1976-04-06 Smithkline Corporation N-(Heterocycl ic-alkyl)-9-xanthenylamines
US3980788A (en) * 1975-09-15 1976-09-14 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting gastric acid secretion
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
US6613797B2 (en) 1999-12-02 2003-09-02 Interlab, Inc. Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins
US8298661B2 (en) 2009-01-30 2012-10-30 W. R. Grace & Co.-Conn Waterproofing membrane
US8298662B2 (en) 2009-08-28 2012-10-30 W.R. Grace & Co.-Conn. Waterproofing membrane
WO2015039334A1 (en) 2013-09-22 2015-03-26 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

Also Published As

Publication number Publication date
US3644420A (en) 1972-02-22
CS186704B2 (en) 1978-12-29
US3754005A (en) 1973-08-21
CA962686A (en) 1975-02-11
FR8016M (de) 1970-08-03
DE1643244A1 (de) 1971-06-09
US3755593A (en) 1973-08-28
CH491104A (fr) 1970-05-31
GB1181673A (en) 1970-02-18
US3855244A (en) 1974-12-17
ES344599A1 (es) 1969-04-16
US3755594A (en) 1973-08-28
US3558779A (en) 1971-01-26
CS186702B2 (en) 1978-12-29
AT296324B (de) 1972-02-10

Similar Documents

Publication Publication Date Title
AT303037B (de) Verfahren zur Herstellung von neuen Chromonen deren salzen, Estern und Amiden
AT262997B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT289824B (de) Verfahren zur Herstellung von neuen Xanthenderivaten, ihren Estern, Amiden und Salzen
AT277227B (de) Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
AT275527B (de) Verfahren zur Herstellung von neuen basischen Estern und ihren Salzen
AT266096B (de) Verfahren zur Herstellung von neuen substituierten Phenylessigsäuren und ihren Salzen
AT289096B (de) Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
AT284842B (de) Verfahren zur Herstellung von neuen Estern und ihren Salzen
AT318612B (de) Verfahren zur Herstellung von neuen Chromonen, ihren Estern und Salzen
AT284110B (de) Verfahren zur Herstellung von neuen N-Phenylindolinderivaten und ihren Salzen
AT270636B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT278005B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT276365B (de) Verfahren zur Herstellung von neuen Pyrrolidinderivaten und ihren Salzen
AT260229B (de) Verfahren zur Herstellung von neuen Isoindolderivaten und ihren Salzen
AT275516B (de) Verfahren zur Herstellung von neuen Piperidinderivaten und ihren Salzen
AT285591B (de) Verfahren zur Herstellung von neuen Spiro-azatetramethylenderivaten und ihren Salzen
AT277222B (de) Verfahren zur Herstellung von neuen Pyrrolinderivaten und ihren Salzen
AT275509B (de) Verfahren zur Herstellung von neuen Benzofuranderivaten und ihren Salzen
AT272331B (de) Verfahren zur Herstellung von neuen Pyrrolidinderivaten und ihren Salzen
AT294814B (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und ihren Salzen
AT275539B (de) Verfahren zur Herstellung von neuen 6,11-Diamino-morphanthridinen und ihren Salzen
AT261611B (de) Verfahren zur Herstellung von neuen Xanthenderivaten und ihren Salzen
AT277998B (de) Verfahren zur Herstellung von neuen Carbazolderivaten und ihren Salzen
AT265292B (de) Verfahren zur Herstellung von neuen Azepinderivaten und ihren Säureadditionssalzen
AT271475B (de) Verfahren zur Herstellung von neuen Flavanderivaten, deren Estern und Estersalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee